Publications by authors named "Shuhui Zhuang"
Article Synopsis
- * Standard treatment often involves chemoimmunotherapy, but many high-risk patients (30-40%) may relapse or develop resistance to drugs.
- * Recent studies highlight the role of epigenetic processes, like DNA methylation and histone modifications, in B-NHL development, paving the way for new targeted therapies that could improve treatment outcomes.
Lymphomas, complex and heterogeneous malignant tumors, originate from the lymphopoietic system. These tumors are notorious for their high recurrence rates and resistance to treatment, which leads to poor prognoses. As ongoing research has shown, epigenetic modifications like DNA methylation, histone modifications, non-coding RNA regulation, and RNA modifications play crucial roles in lymphoma pathogenesis.
View Article and Find Full Text PDF